Medical Articles 7/31

Posted by rob on July 31, 2007 under Uncategorized | Be the First to Comment

Diminished CD10, CD13, and CD15 expression in a differentiated granulocyte population in CML.

Reduced
intensity allogeneic umbilical cord blood transplantation in children
and adolescent recipients with malignant and non-malignant diseases.
Development of an Integrated Assay for Detection of BCR-ABL RNA.
Recent development of IMP dehydrogenase inhibitors for the treatment of cancer.
Sweet’s syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis.

Cyclin
B1 is commonly expressed in the cytoplasm of primary human acute
myelogenous leukemia cells and serves as a leukemia-associated antigen
associated with autoantibody response in a subset of patients.

Medical Articles 7/27

Posted by rob on July 28, 2007 under Uncategorized | Be the First to Comment

Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia.

Chromosomal aberrations in congenital bone marrow failure disorders-an early indicator for leukemogenesis?
Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data.
[Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype]

Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents.

Medical Articles 7/24

Posted by rob on July 24, 2007 under Uncategorized | Be the First to Comment

Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non small-cell lung cancer.

The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

Hematopoietic stem cell transplantation in australia and new zealand, 1992-2004.

Medical Articles 7/20

Posted by rob on July 20, 2007 under Uncategorized | Be the First to Comment

BCR-Tyrosine
177 Plays an Essential Role in Ras and Akt Activation and in Human
Hematopoietic Progenitor Transformation in Chronic Myelogenous Leukemia.

Structural Analysis Identifies Imidazo[1,2-b]Pyridazines as PIM Kinase Inhibitors with In vitro Antileukemic Activity.
The
histone deacetylase inhibitor ITF2357 has anti-leukemic activity in
vitro and in vivo and inhibits IL-6 and VEGF production by stromal
cells.
[Bone marrow WT1 gene expression and clinical significance in chronic myelogenous leukemia.]
CJY,
an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in
doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
Expression of components of the IGF axis in childhood acute myelogenous leukemia.
Synergistic
Interactions between Vorinostat and Sorafenib in Chronic Myelogenous
Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation.

BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia.

Medical Articles 7/20

Posted by rob on July 18, 2007 under Uncategorized | Be the First to Comment

[Reappearance of t(12;17)-positive primary myelofibrosis following Ph+ CML cell reduction by imatinib]

[Gemtuzumab ozogamicin as monotherapy and combination therapy for acute myelogenous leukemia]
[Leg ulcer due to hydroxyurea. A case report]

Antiproliferative activity of Citrus juices and HPLC evaluation of their flavonoid composition.

Medical Articles 7/14

Posted by rob on July 14, 2007 under Uncategorized | Be the First to Comment

Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis.

Severe periorbital edema secondary to imatinib mesylate for chronic myelogenous leukemia.
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.
WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers.
An optimal dynamic inversion-based neuro-adaptive approach for treatment of chronic myelogenous leukemia.

Born
to Be Exported: COOH-Terminal Nuclear Export Signals of Different
Strength Ensure Cytoplasmic Accumulation of Nucleophosmin Leukemic
Mutants.

Medical Articles 7/13

Posted by rob on July 13, 2007 under Uncategorized | Be the First to Comment

Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis.

Severe periorbital edema secondary to imatinib mesylate for chronic myelogenous leukemia.
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.
WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers.
An optimal dynamic inversion-based neuro-adaptive approach for treatment of chronic myelogenous leukemia.

Born
to Be Exported: COOH-Terminal Nuclear Export Signals of Different
Strength Ensure Cytoplasmic Accumulation of Nucleophosmin Leukemic
Mutants.

Medical Articles 7/9

Posted by rob on July 10, 2007 under Uncategorized | Be the First to Comment

The
clinical, haematological and morphological profile of patients with
myelodysplastic syndromes: A single institution experience from Turkey.

Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
DNA methyltransferases as targets for cancer therapy.

[Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders]

Medical Articles 7/6

Posted by rob on July 6, 2007 under Uncategorized | Be the First to Comment

Depsipeptide
(FK228) Preferentially Induces Apoptosis in BCR/ABL-Expressing Cell
Lines and Cells from Patients with Chronic Myelogenous Leukemia in
Blast Crisis.

Successful
interim therapy with imatinib prior to allogeneic stem cell
transplantation in Philadelphia chromosome-positive acute myeloid
leukemia.

New molecular therapy targets in acute myeloid leukemia.

Medical Articles 7/5

Posted by rob on July 5, 2007 under Uncategorized | Be the First to Comment

Repeated
infusions of donor-derived cytokine-induced killer cells in patients
relapsing after allogeneic stem cell transplantation: a phase I study.

[Nucleophosmin mutations in hematological malignancies - review.]

[Abnormal activation of tyrosine kinases and its role in the pathogenesis of hematological malignancies - review.]

Medical Articles 7/3

Posted by rob on July 3, 2007 under Uncategorized | Be the First to Comment

Ras as a therapeutic target in hematologic malignancies.

Repeated
relapses of acute myelogenous leukemia in the isolated extramedullary
sites following allogeneic bone marrow transplantations.
Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
Optimal control of treatment in a mathematical model of chronic myelogenous leukemia.
Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells.

Distinctive
expression of myelomonocytic markers and down-regulation of CD34 in
acute myelogenous leukaemia with FLT3 tandem duplication and
nucleophosmin mutation.

home top